SCHEMBL25916362

SCHEMBL25916362

O=C(Nc1cc(Cl)ccc1-c1nc2ccccc2s1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.61
NPSR1 Q6W5P4 1/20 0.61
HPGD P15428 3/20 0.60
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
ALDH1A1 P00352 3/20 0.59
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
KDM4E B2RXH2 1/20 0.59
MMP2 P08253 1/20 0.58
MMP9 P14780 1/20 0.58
MMP8 P22894 1/20 0.58
MMP13 P45452 1/20 0.58
TP53 P04637 4/20 0.57
RXFP1 Q9HBX9 3/20 0.56
KCNMA1 Q12791 1/20 0.53
USP2 O75604 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30362693 1.00 MAPT (0.61) MAPTNPSR1HPGDMEN1KMT2A
SCHEMBL30362639 0.89 MAPT (0.55) MAPTNPSR1HPGDMEN1KMT2A
SCHEMBL25916341 0.89 MAPT (0.55) MAPTNPSR1HPGDMEN1KMT2A
SCHEMBL30362646 0.86 HPGD (0.78) MAPTHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL25916294 0.86 HPGD (0.78) MAPTHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL25916842 0.86 MAPT (0.66) MAPTNPSR1HPGDMEN1KMT2A
SCHEMBL25916406 0.85 MAPT (0.58) MAPTNPSR1HPGDSMN1; SMN2ALDH1A1
SCHEMBL25916333 0.83 MAPT (0.75) MAPTHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL30362804 0.83 MAPT (0.75) MAPTHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL25916339 0.83 MAPT (0.59) MAPTNPSR1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768631-A Fluorescent composition comprising at least one benzoxazole compound for protecting products 犯罪科学技术公司 2023-03-07 CN claimed
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS Crime Science Technology (FR) 2023-07-27 US disclosed
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS Crime Science Technology (FR) 2023-07-27 US disclosed
CN-115768631-A Fluorescent composition comprising at least one benzoxazole compound for protecting products 犯罪科学技术公司 2023-03-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS TUBB3, TUBA3C, PHB1 MAPT 318/4885NPSR1 4524/4885HPGD 1287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.